Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester

Details for Australian Patent Application No. 2004285354 (hide)

Owner Takeda Pharmaceutical Company Limited

Inventors Kawano, Tetsuya; Hamaguchi, Naoru; Doken, Kazuhiro; Koyama, Hiroyoshi

Agent Griffith Hack

Pub. Number AU-B-2004285354

PCT Pub. Number WO2005/041962

Priority 2003-371679 31.10.03 JP

Filing date 21 October 2004

Wipo publication date 12 May 2005

Acceptance publication date 17 September 2009

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/24 (2006.01) Medicinal preparations characterised by special physical form - Layered or laminated unitary dosage forms

A61K 31/4439 (2006.01)

A61K 31/64 (2006.01) - Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/041962 Priority application(s): WO2005/041962

17 September 2009 Application Accepted

  Published as AU-B-2004285354

21 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004285363-Bactericide composition and method of controlling plant disease

2004285351-Material in gel state